 |
|
 |
 |

Home > Company Index > Drugs > Biotechnology-Research > Illumina, Inc.
 |
Illumina, Inc. |
 |
 |
 |
NEWS FROM THE STANDARD |
 |
Biotech: Mining the Genome
Jul 02 2001 12:00 AM PDT
Biotechies Swarm Into San Diego
Jun 26 2001 06:54 AM PDT
PROFILE |
 |
Illumina enlightens. The company develops instruments that measure genetic variation in individuals to devise new treatments for various diseases. Illumina's flagship BeadArray technology facilitates multiple genetic assays by attaching microscopic beads to fiber-optic bundles; each bead holds a different molecule or DNA sequence. The bundle is then dipped into a test sample, and a laser detects which beads reacted with the sample. Illumina is also developing the Oligator technology, which prepares DNA segments for BeadArray testing. Illumina collaborates with Applied Biosystems, Dow Chemical, and Third Wave Technologies, among others. Through the CW Group, director Charles Hartman owns about 15% of the company.
COMPETITION |
 |
Luminex Corporation (LMNX)
Sequenom, Inc. (SQNM)
Variagenics, Inc. (VGNX)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 1.30
1-Yr. Sales Growth: 174.3%
Employees: 105
Revenue per employee: $12,380.95
KEY PEOPLE |
 |
Jay T. Flatley
CEO
Timothy M. Kish
CFO
CONTACT INFO |
 |
9390 Towne Centre Dr., Ste. 200
San Diego, CA 92121
US
Phone: 858-587-4290
Fax: 858-587-4297
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |